Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 1.34
CASM's Cash to Debt is ranked lower than
55% of the 202 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.81 vs. CASM: 1.34 )
Ranked among companies with meaningful Cash to Debt only.
CASM' s Cash to Debt Range Over the Past 10 Years
Min: 0.07  Med: 0.67 Max: No Debt
Current: 1.34
Equity to Asset 0.41
CASM's Equity to Asset is ranked lower than
78% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.62 vs. CASM: 0.41 )
Ranked among companies with meaningful Equity to Asset only.
CASM' s Equity to Asset Range Over the Past 10 Years
Min: 0.21  Med: 0.58 Max: 0.86
Current: 0.41
0.21
0.86
F-Score: 4
Z-Score: 0.63
M-Score: -2.92
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -27.80
CASM's Operating margin (%) is ranked lower than
76% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.55 vs. CASM: -27.80 )
Ranked among companies with meaningful Operating margin (%) only.
CASM' s Operating margin (%) Range Over the Past 10 Years
Min: -47.7  Med: -21.72 Max: 8.46
Current: -27.8
-47.7
8.46
Net-margin (%) -17.30
CASM's Net-margin (%) is ranked lower than
70% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.00 vs. CASM: -17.30 )
Ranked among companies with meaningful Net-margin (%) only.
CASM' s Net-margin (%) Range Over the Past 10 Years
Min: -47.28  Med: -22.00 Max: 4.96
Current: -17.3
-47.28
4.96
ROE (%) -67.56
CASM's ROE (%) is ranked lower than
88% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.62 vs. CASM: -67.56 )
Ranked among companies with meaningful ROE (%) only.
CASM' s ROE (%) Range Over the Past 10 Years
Min: -187.76  Med: -46.67 Max: 16.07
Current: -67.56
-187.76
16.07
ROA (%) -20.44
CASM's ROA (%) is ranked lower than
74% of the 204 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.86 vs. CASM: -20.44 )
Ranked among companies with meaningful ROA (%) only.
CASM' s ROA (%) Range Over the Past 10 Years
Min: -53.75  Med: -30.02 Max: 8.88
Current: -20.44
-53.75
8.88
ROC (Joel Greenblatt) (%) -115.71
CASM's ROC (Joel Greenblatt) (%) is ranked lower than
80% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.53 vs. CASM: -115.71 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CASM' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -177.41  Med: -72.63 Max: 28.54
Current: -115.71
-177.41
28.54
Revenue Growth (3Y)(%) -21.00
CASM's Revenue Growth (3Y)(%) is ranked lower than
89% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.10 vs. CASM: -21.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CASM' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -22.5  Med: 8.50 Max: 25.3
Current: -21
-22.5
25.3
EBITDA Growth (3Y)(%) -28.00
CASM's EBITDA Growth (3Y)(%) is ranked lower than
89% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. CASM: -28.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CASM' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -34  Med: -0.35 Max: 109.2
Current: -28
-34
109.2
EPS Growth (3Y)(%) -20.40
CASM's EPS Growth (3Y)(%) is ranked lower than
77% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.90 vs. CASM: -20.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CASM' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -42.2  Med: 0.85 Max: 147.6
Current: -20.4
-42.2
147.6
» CASM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

CASM Guru Trades in Q2 2015

Jim Simons 55,800 sh (+2.79%)
» More
Q3 2015

CASM Guru Trades in Q3 2015

Jim Simons 90,600 sh (+62.37%)
» More
Q4 2015

CASM Guru Trades in Q4 2015

Jim Simons 131,000 sh (+44.59%)
» More
Q1 2016

CASM Guru Trades in Q1 2016

Jim Simons 153,600 sh (+17.25%)
» More
» Details

Insider Trades

Latest Guru Trades with CASM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NAS:UNIS, AMEX:MLSS, ASX:CMP, AMEX:ISR, ASX:SDI » details
Traded in other countries:UM1.Germany,
CAS Medical Systems Inc is a medical technology company. The Company develops, manufactures and markets non-invasive patient monitoring products that are vital to patient care. Its products include FORE-SIGHT and FORE-SIGHT ELITE brand.

CAS Medical Systems Inc is a Delaware corporation organized in 1984. It is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products that are vital to patient care. Its products include the FORE-SIGHT Absolute Tissue Oximeter and sensors, and its Traditional Monitoring products which include MAXNIBP blood pressure measurement technology, bedside monitoring products, and neonatal vital signs supplies. These products are designed to provide accurate, non-invasive, biologic measurements that guide clinicians to provide better patient care. The Company reports two categories of revenue within one reportable business unit: Tissue Oximetry Monitoring includes sales of the Companys FORE-SIGHT Absolute Tissue Oximeter monitors, sensors and accessories; and Traditional Monitoring includes sales of the Companys traditional vital signs products and services including sales to Original Equipment Manufacturers (OEM) of the Companys proprietary non-invasive blood pressure technology (MAXNIBP) for inclusion in the OEM customers own multi-parameter monitors; bedside vital signs monitors and accessories incorporating various combinations of measurement parameters for both human and veterinary use such as MAXNIBP non-invasive blood pressure, pulse oximetry, electrocardiography (ECG), temperature, and capnography (CO² measurements); neonatal intensive care vital signs supplies including electrodes and skin temperature probes and service repair. The Company markets its products through hospital, surgery center and outpatient facility, homecare, veterinary and emergency medical distribution channels. The Company competes in the broader medical equipment market for patient monitoring equipment and supplies. Medical products of the type currently being marketed and under development by the Company are subject to regulation under the Food, Drug and Cosmetic Act (the FD&C Act) and numerous acts and amendments such as the Quality System Regulations (QSR), often referred to as Good Manufacturing Practices (GMP's). The Company also offers a line of non-invasive vital signs monitoring products for various general care settings, such as hospital wards, outpatient medical surgical units, recovery rooms, procedure labs, physician offices, long term care facilities, and emergency response settings.

Ratios

vs
industry
vs
history
P/S 2.14
CASM's P/S is ranked higher than
55% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.59 vs. CASM: 2.14 )
Ranked among companies with meaningful P/S only.
CASM' s P/S Range Over the Past 10 Years
Min: 0.38  Med: 1.36 Max: 6.1
Current: 2.14
0.38
6.1
Current Ratio 2.23
CASM's Current Ratio is ranked lower than
56% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. CASM: 2.23 )
Ranked among companies with meaningful Current Ratio only.
CASM' s Current Ratio Range Over the Past 10 Years
Min: 2.11  Med: 3.47 Max: 9.01
Current: 2.23
2.11
9.01
Quick Ratio 1.98
CASM's Quick Ratio is ranked higher than
58% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. CASM: 1.98 )
Ranked among companies with meaningful Quick Ratio only.
CASM' s Quick Ratio Range Over the Past 10 Years
Min: 0.87  Med: 2.04 Max: 7.36
Current: 1.98
0.87
7.36
Days Inventory 71.24
CASM's Days Inventory is ranked higher than
83% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.83 vs. CASM: 71.24 )
Ranked among companies with meaningful Days Inventory only.
CASM' s Days Inventory Range Over the Past 10 Years
Min: 63.1  Med: 107.53 Max: 136.88
Current: 71.24
63.1
136.88
Days Sales Outstanding 54.21
CASM's Days Sales Outstanding is ranked higher than
66% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.25 vs. CASM: 54.21 )
Ranked among companies with meaningful Days Sales Outstanding only.
CASM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.05  Med: 40.80 Max: 55.29
Current: 54.21
33.05
55.29
Days Payable 53.12
CASM's Days Payable is ranked lower than
53% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 55.30 vs. CASM: 53.12 )
Ranked among companies with meaningful Days Payable only.
CASM' s Days Payable Range Over the Past 10 Years
Min: 22.01  Med: 38.85 Max: 59.01
Current: 53.12
22.01
59.01

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 1.59
CASM's Price/Median PS Value is ranked lower than
78% of the 177 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.04 vs. CASM: 1.59 )
Ranked among companies with meaningful Price/Median PS Value only.
CASM' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.16  Med: 0.91 Max: 2.76
Current: 1.59
0.16
2.76
Earnings Yield (Greenblatt) (%) -9.99
CASM's Earnings Yield (Greenblatt) (%) is ranked lower than
77% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. CASM: -9.99 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CASM' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -10.04  Med: 3.05 Max: 5.4
Current: -9.99
-10.04
5.4
Forward Rate of Return (Yacktman) (%) -25.91
CASM's Forward Rate of Return (Yacktman) (%) is ranked lower than
94% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.42 vs. CASM: -25.91 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CASM' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -27.2  Med: -2.90 Max: 41.5
Current: -25.91
-27.2
41.5

More Statistics

Revenue (TTM) (Mil) $22.54
EPS (TTM) $ -0.20
Beta-0.94
Short Percentage of Float0.48%
52-Week Range $1.02 - 2.09
Shares Outstanding (Mil)27.33
» More Articles for CASM

Headlines

Articles On GuruFocus.com
CAS Medical Systems Inc. (CASM) CEO Thomas M Patton buys 20,000 Shares Dec 08 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Nov 10 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Aug 04 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) May 05 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Nov 05 2009 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Aug 12 2009 
CAS Medical Systems Inc. Reports Operating Results (10-Q) May 06 2009 

More From Other Websites
CASMED to Present at Upcoming Investment Conferences May 25 2016
CASM: Zacks SCR Initiates Coverage of CAS Medical. May 24 2016
CAS MEDICAL SYSTEMS INC Financials May 20 2016
CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q1, 2016 By the Numbers May 17 2016
CAS MEDICAL SYSTEMS INC Files SEC form 10-Q, Quarterly Report May 11 2016
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 05 2016
CASMED Reports First-Quarter 2016 Financial Results May 05 2016
Q1 2016 CAS Medical Systems Inc Earnings Release - Before Market Open May 05 2016
CASMED to Report First Quarter 2016 Financial Results and Hold Conference Call on May 5 Apr 28 2016
CAS MEDICAL SYSTEMS INC Files SEC form 10-K, Annual Report Mar 30 2016
CASMED Sells Neonatal Intensive Care Disposables Product Line Mar 29 2016
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Mar 29 2016
CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 14 2016
Edited Transcript of CASM earnings conference call or presentation 9-Mar-16 3:00pm GMT Mar 09 2016
CAS Medical Systems Inc Earnings Call scheduled for 10:00 am ET today Mar 09 2016
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 09 2016
CASMED Reports 2015 Fourth Quarter and Full Year Financial Results Mar 09 2016
Q4 2015 CAS Medical Systems Inc Earnings Release - Before Market Open Mar 09 2016
CASMED to Present at the ROTH Conference Mar 07 2016
CASMED to Report Fourth Quarter and 2015 Full-Year Financial Results and Hold Conference Call on... Mar 03 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)